During the past decade, Onkologie Bellevue conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Onkologie Bellevue" #1 collaborator was "Palleos Healthcare GmbH" with 1 trials as a collaborator, "Stiftung Swiss Tumor Institute" with 1 trials as a collaborator, "The Belgian Society of Medical Oncology" with 1 trials as a collaborator and "University of Zurich" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Onkologie Bellevue" are "Biosimilar" (1 trials), "Bone Metastases" (1 trials), "Breast Cancer" (1 trials), "Early Breast Cancer" (1 trials) and "HER2-positive Breast Cancer" (1 trials). Many other conditions were trialed in "Onkologie Bellevue" in a lesser frequency.

Most popular intervention types in "Onkologie Bellevue" are "Drug" (2 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Activity program" (1 trials), "Control" (1 trials), "Denosumab (reduced dosing)" (1 trials), "Denosumab (standard dosing)" (1 trials) and "Endocrine-Therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Onkologie Bellevue" are 3 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Onkologie Bellevue". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Onkologie Bellevue, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Onkologie Bellevue, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".